You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 2, January 24, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Recurrence Risk of Oculorespiratory Syndrome After Influenza Vaccination: Randomized Controlled Trial of Previously Affected Persons—Correction

Arch Intern Med. 2005;165:145.

Omission of Financial Disclosure. In the Original Investigation by De Serres et al titled "Recurrence Risk of Oculorespiratory Syndrome After Influenza Vaccination: Randomized Controlled Trial of Previously Affected Persons," published in the November 8 issue of the ARCHIVES (2004;164:2266-2272), the Financial Disclosure was inadvertently omitted on page 2266. The statement of Financial Disclosure should have appeared beneath the Author Affiliations and read as follows: "Financial Disclosure: Drs De Serres, Skowronski, and Duval have received research grants and Dr Skowronski has received honoraria from Aventis Pasteur and Shire Biologics. Dr Guay has received grants from Wyeth-Ayerst Canada, Biochem Pharma, and Merck Frosst Canada." The journal regrets the error.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.